Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Koegl

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Nature Chemical Biology|July 5, 2016
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibitionAnja F Hohmann, Laetitia J Martin, Jessica L Minder, et al.
Molecular and Cellular Biology|January 17, 2003
Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterolKerstin Otte, Harald Kranz, Ingo Kober, et al.
Journal of Medicinal Chemistry|July 15, 2024
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical AssaysThomas Gerstberger, Helmut Berger, Frank H Büttner, et al.
Plos Pathogens|August 17, 2013
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replicationSamantha J Griffiths, Manfred Koegl, Chris Boutell, et al.
Oncotarget|March 18, 2020
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasisStefanie Schlager, Carina Salomon, Sabine Olt, et al.
Journal of Medicinal Chemistry|February 12, 2019
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding FunctionsJohannes Popow, Heribert Arnhof, Gerd Bader, et al.
Plos Pathogens|September 5, 2009
Evolutionarily conserved herpesviral protein interaction networksEven Fossum, Caroline C Friedel, Seesandra V Rajagopala, et al.
ACS Chemical Biology|July 3, 2024
Confounding Factors in Targeted Degradation of Short-Lived ProteinsVesna Vetma, Laura Casares Perez, Ján Eliaš, et al.
Journal of Medicinal Chemistry|February 26, 2016
Structure-Based Design of an in Vivo Active Selective BRD9 InhibitorLaetitia J Martin, Manfred Koegl, Gerd Bader, et al.
Nature Communications|October 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivoChristiane Kofink, Nicole Trainor, Barbara Mair, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Nature Chemical Biology|July 5, 2016
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibitionAnja F Hohmann, Laetitia J Martin, Jessica L Minder, et al.
Molecular and Cellular Biology|January 17, 2003
Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterolKerstin Otte, Harald Kranz, Ingo Kober, et al.
Journal of Medicinal Chemistry|July 15, 2024
Chasing Red Herrings: Palladium Metal Salt Impurities Feigning KRAS Activity in Biochemical AssaysThomas Gerstberger, Helmut Berger, Frank H Büttner, et al.
Plos Pathogens|August 17, 2013
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replicationSamantha J Griffiths, Manfred Koegl, Chris Boutell, et al.
Oncotarget|March 18, 2020
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasisStefanie Schlager, Carina Salomon, Sabine Olt, et al.
Journal of Medicinal Chemistry|February 12, 2019
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding FunctionsJohannes Popow, Heribert Arnhof, Gerd Bader, et al.
Plos Pathogens|September 5, 2009
Evolutionarily conserved herpesviral protein interaction networksEven Fossum, Caroline C Friedel, Seesandra V Rajagopala, et al.
ACS Chemical Biology|July 3, 2024
Confounding Factors in Targeted Degradation of Short-Lived ProteinsVesna Vetma, Laura Casares Perez, Ján Eliaš, et al.
Journal of Medicinal Chemistry|February 26, 2016
Structure-Based Design of an in Vivo Active Selective BRD9 InhibitorLaetitia J Martin, Manfred Koegl, Gerd Bader, et al.
Nature Communications|October 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivoChristiane Kofink, Nicole Trainor, Barbara Mair, et al.
Pageof 4